Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that it will host a virtual KOL event discussing the approval of YCANTH™ (cantharidin) topical solution for the treatment of …

Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution Read More

Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced that that Ted White, Verrica President and CEO, will participate in a fireside chat at the …

Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference Read More

Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Announces Presentation of Lesion Clearance Data from an Ongoing Phase 2 Study of VP-315

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, this week announced the presentation of lesion clearance data from Part 1 of an ongoing Phase 2 …

Verrica Pharmaceuticals Announces Presentation of Lesion Clearance Data from an Ongoing Phase 2 Study of VP-315 Read More

Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals to Present Clinical Data on VP-315 for Basal Cell Carcinoma Treatment at AAD 2023 Innovation Academy

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced the acceptance of an abstract that will feature clinical data from the Company’s ongoing Phase 2 …

Verrica Pharmaceuticals to Present Clinical Data on VP-315 for Basal Cell Carcinoma Treatment at AAD 2023 Innovation Academy Read More